Gennace Ronald E MD North Arlington, NJ - 07031

Gennace Ronald E MD is categorized under Orthopedic Doctors and Physicians in North Arlington, NJ and active since 1980.

Gennace Ronald E MD was established in 1980, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Ronald Gennace at the company’s single location by writing to 312 Belleville Turnpike # 2a, North Arlington, New Jersey NJ 07031 or by phoning (201) 997-8777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Gennace Ronald E MD
Contact Person: Ronald Gennace
Address: 312 Belleville Turnpike # 2a, North Arlington, New Jersey 07031
Phone Number: (201) 997-8777
Annual Revenue (USD): $500.000 to $999.999
Founded: 1980
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Doctors and Physicians
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Gennace Ronald E MD was started in 1980 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Ronald Gennace for inquiries that concern Gennace Ronald E MD by calling the company number (201) 997-8777, as your correspondence is most welcome. Additionally, the physical location of the single location of Gennace Ronald E MD can be found at the coordinates 40.7802,-74.13542 as well as the street address 312 Belleville Turnpike # 2a in North Arlington, New Jersey 07031.

For its online presence, you may visit Gennace Ronald E MD’s website at and engage with its social media outlets through on Twitter and on Facebook.